Ross Edgar

635 total citations
31 papers, 409 citations indexed

About

Ross Edgar is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Ross Edgar has authored 31 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Ross Edgar's work include Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Protease and Inhibitor Mechanisms (6 papers). Ross Edgar is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers), Pulmonary Hypertension Research and Treatments (11 papers) and Protease and Inhibitor Mechanisms (6 papers). Ross Edgar collaborates with scholars based in United Kingdom, Saudi Arabia and Singapore. Ross Edgar's co-authors include Alice Turner, Robert A. Stockley, Elizabeth Sapey, David Parr, James Stockley, Dimitrios Kantas, Philip N. Newsome, Sarah Townsend, Paul Ellis and Susan Bayliss and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Thorax.

In The Last Decade

Ross Edgar

30 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ross Edgar United Kingdom 10 243 145 118 72 43 31 409
Ruby Gupta United States 10 126 0.5× 55 0.4× 88 0.7× 11 0.2× 23 0.5× 33 285
Charlotte S. Ulrik Denmark 6 299 1.2× 167 1.2× 132 1.1× 83 1.2× 78 1.8× 8 485
Melody Campbell United States 6 117 0.5× 107 0.7× 42 0.4× 25 0.3× 48 1.1× 7 316
Satoru Yonekura Japan 9 56 0.2× 42 0.3× 100 0.8× 18 0.3× 8 0.2× 28 282
Emre Yekedüz Türkiye 9 107 0.4× 38 0.3× 163 1.4× 15 0.2× 4 0.1× 63 296
Catherine Roth United States 9 172 0.7× 93 0.6× 101 0.9× 169 2.3× 16 0.4× 21 459
Bruce Kressel United States 6 151 0.6× 27 0.2× 130 1.1× 21 0.3× 42 1.0× 9 298
Anastasia Laudisi Italy 9 62 0.3× 83 0.6× 103 0.9× 60 0.8× 37 0.9× 13 343
Nobuyuki Yamamoto Japan 13 132 0.5× 101 0.7× 294 2.5× 24 0.3× 38 0.9× 64 527
Hideto Itoh Japan 9 138 0.6× 38 0.3× 137 1.2× 103 1.4× 15 0.3× 23 339

Countries citing papers authored by Ross Edgar

Since Specialization
Citations

This map shows the geographic impact of Ross Edgar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Edgar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Edgar more than expected).

Fields of papers citing papers by Ross Edgar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Edgar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Edgar. The network helps show where Ross Edgar may publish in the future.

Co-authorship network of co-authors of Ross Edgar

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Edgar. A scholar is included among the top collaborators of Ross Edgar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Edgar. Ross Edgar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sapey, Elizabeth, Louise Crowley, Ross Edgar, et al.. (2024). Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools. Orphanet Journal of Rare Diseases. 19(1). 130–130. 1 indexed citations
2.
Patel, Ketan, Anita Pye, Ross Edgar, et al.. (2024). Cluster randomised controlled trial of specialist-led integrated COPD care (INTEGR COPD). Thorax. 79(3). 209–218. 1 indexed citations
3.
Sapey, Elizabeth, Zehra Yonel, Ross Edgar, et al.. (2020). The clinical and inflammatory relationships between periodontitis and chronic obstructive pulmonary disease. Journal Of Clinical Periodontology. 47(9). 1040–1052. 36 indexed citations
4.
Trethewey, Samuel P., et al.. (2019). Late presentation of acute hypercapnic respiratory failure carries a high mortality risk in COPD patients treated with ward-based NIV. Respiratory Medicine. 151. 128–132. 7 indexed citations
5.
Trethewey, Samuel P., et al.. (2019). Temporal trends in survival following ward‐based NIV for acute hypercapnic respiratory failure in patients with COPD. The Clinical Respiratory Journal. 13(3). 184–188. 7 indexed citations
6.
Stockley, Robert A., et al.. (2018). Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?. Respiratory Research. 19(1). 137–137. 15 indexed citations
7.
Trethewey, Samuel P., Ross Edgar, Alice Turner, & Rahul Mukherjee. (2018). Ward-Based Non-Invasive Ventilation in Acute Exacerbations of COPD: A Narrative Review of Current Practice and Outcomes in the UK. Healthcare. 6(4). 145–145. 8 indexed citations
8.
Sabbagh, Doñah, Behrad Barmayehvar, Thanh Xuan Nguyen, Ross Edgar, & Alice Turner. (2018). Managing panniculitis in alpha-1 antitrypsin deficiency: Systematic review of evidence behind treatment. University of Birmingham Research Portal (University of Birmingham). 7(1). 1–8. 6 indexed citations
9.
Edgar, Ross, et al.. (2017). Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. International Journal of COPD. Volume 12. 1295–1308. 54 indexed citations
10.
Stockley, James, et al.. (2017). Maximal mid-expiratory flow detects early lung disease in α1-antitrypsin deficiency. European Respiratory Journal. 49(3). 1602055–1602055. 48 indexed citations
11.
Parr, David, et al.. (2016). Lung density associates with survival in alpha 1 antitrypsin deficient patients. Respiratory Medicine. 112. 81–87. 27 indexed citations
12.
Stockley, Robert A., et al.. (2016). Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?. International Journal of COPD. Volume 11. 1745–1756. 35 indexed citations
13.
Stone, Helen, Ross Edgar, R. Thompson, & Robert A. Stockley. (2015). Lung Transplantation in Alpha-1-Antitrypsin Deficiency. COPD Journal of Chronic Obstructive Pulmonary Disease. 13(2). 146–152. 20 indexed citations
14.
Stone, Helen, et al.. (2015). Lung transplantation in alpha 1 antitrypsin deficiency. PA4548–PA4548. 1 indexed citations
15.
16.
Edgar, Ross, et al.. (2014). P58 A Comparison Between The Clinical Features Of Pisz And Pizz Patients With Alpha-1 Antitrypsin Deficiency. Thorax. 69(Suppl 2). A100–A100. 3 indexed citations
17.
Subramanian, Deepak, et al.. (2013). Prevalence and radiological outcomes of lung nodules in alpha 1-antitrypsin deficiency. Respiratory Medicine. 107(6). 863–869. 1 indexed citations
18.
Subramanian, Deepak, et al.. (2012). Assessment of Pulmonary Neutrophilic Inflammation in Emphysema by Quantitative Positron Emission Tomography. American Journal of Respiratory and Critical Care Medicine. 186(11). 1125–1132. 49 indexed citations
19.
Edgar, Ross, et al.. (2012). P81 Lung Transplantation in Alpha-1-Antitrypsin Deficiency. Thorax. 67(Suppl 2). A99.1–A99. 1 indexed citations
20.
Edgar, Ross, et al.. (2011). Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD). European Respiratory Journal. 38(Suppl 55). p3514–p3514. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruby Gupta Breakdown of academic impact, for papers by Charlotte S. Ulrik Breakdown of academic impact, for papers by Melody Campbell Breakdown of academic impact, for papers by Satoru Yonekura Breakdown of academic impact, for papers by Emre Yekedüz Breakdown of academic impact, for papers by Catherine Roth Breakdown of academic impact, for papers by Bruce Kressel Breakdown of academic impact, for papers by Anastasia Laudisi Breakdown of academic impact, for papers by Nobuyuki Yamamoto Breakdown of academic impact, for papers by Hideto Itoh
Rankless by CCL
2026